The outcome of the board meeting held on September 6, 2023 includes the approval of a slump sale of the API business, an investment in Synthimed Labs Private Limited, a grant of unsecured loan, approval of the amalgamation proposal of Ind-Swift Limited, execution of various agreements/documents, convening of an extraordinary general meeting, and appointment of a scrutinizer.